1. Home
  2. NEPH vs DYAI Comparison

NEPH vs DYAI Comparison

Compare NEPH & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.01

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Logo Dyadic International Inc.

DYAI

Dyadic International Inc.

HOLD

Current Price

$0.88

Market Cap

32.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
DYAI
Founded
1997
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.0M
32.5M
IPO Year
2004
2003

Fundamental Metrics

Financial Performance
Metric
NEPH
DYAI
Price
$3.01
$0.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$3.00
AVG Volume (30 Days)
24.3K
78.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
1000.00
N/A
EPS
0.11
N/A
Revenue
$18,789,000.00
$3,090,345.00
Revenue This Year
$11.24
$131.04
Revenue Next Year
$11.58
N/A
P/E Ratio
$26.82
N/A
Revenue Growth
32.67
N/A
52 Week Low
$1.78
$0.65
52 Week High
$6.42
$1.35

Technical Indicators

Market Signals
Indicator
NEPH
DYAI
Relative Strength Index (RSI) 44.52 54.36
Support Level $2.79 $0.83
Resistance Level $3.21 $1.00
Average True Range (ATR) 0.17 0.07
MACD 0.05 0.00
Stochastic Oscillator 66.02 74.69

Price Performance

Historical Comparison
NEPH
DYAI

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About DYAI Dyadic International Inc.

Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: